Table 4. Unadjusted disease-free and overall survival by treatment at 72 months median follow-up for the 324a patients included in the Q-TWiST-analysis.
| No. of patients | No. of events | 5-year DFS%±s.e. | P-value | No. of dead | 5-year OS%±s.e. | P-value | |
|---|---|---|---|---|---|---|---|
| DI-EC | 159 | 79 | 52±4 | 0.11 | 55 | 71±4 | 0.25 |
| SD-CT | 165 | 97 | 44±4 | 67 | 63±4 |
Abbreviations: DI-EC=dose-intensive epirubicin cyclophosphamide; SD-CT=standard dose chemotherapy (ACx4-CMFx3); DFS=disease-free survival; OS=overall survival; s.e.=standard error; P=P-value.
a
Excluding 20 patients who did not receive any of their prescribed treatment (6 in the SD-CT group and 14 in the DI-EC group).